These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 9693368

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Inhibition of Cdk4 activity enhances translation of p27kip1 in quiescent Rb-negative cells.
    González T, Seoane M, Caamaño P, Viñuela J, Domínguez F, Zalvide J.
    J Biol Chem; 2003 Apr 11; 278(15):12688-95. PubMed ID: 12566456
    [Abstract] [Full Text] [Related]

  • 23. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
    McConnell BB, Gregory FJ, Stott FJ, Hara E, Peters G.
    Mol Cell Biol; 1999 Mar 11; 19(3):1981-9. PubMed ID: 10022885
    [Abstract] [Full Text] [Related]

  • 24. Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells.
    Agrawal D, Hauser P, McPherson F, Dong F, Garcia A, Pledger WJ.
    Mol Cell Biol; 1996 Aug 11; 16(8):4327-36. PubMed ID: 8754833
    [Abstract] [Full Text] [Related]

  • 25. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V, Lahusen T, Leethanakul C, Igishi T, Kremer M, Quintanilla-Martinez L, Ensley JF, Sausville EA, Gutkind JS, Senderowicz AM.
    Clin Cancer Res; 2002 Nov 11; 8(11):3549-60. PubMed ID: 12429646
    [Abstract] [Full Text] [Related]

  • 26. Cdk6-cyclin D3 complex evades inhibition by inhibitor proteins and uniquely controls cell's proliferation competence.
    Lin J, Jinno S, Okayama H.
    Oncogene; 2001 Apr 12; 20(16):2000-9. PubMed ID: 11360184
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.
    Schrantz N, Beney GE, Auffredou MT, Bourgeade MF, Leca G, Vazquez A.
    J Immunol; 2000 Oct 15; 165(8):4346-52. PubMed ID: 11035070
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points.
    Mateyak MK, Obaya AJ, Sedivy JM.
    Mol Cell Biol; 1999 Jul 15; 19(7):4672-83. PubMed ID: 10373516
    [Abstract] [Full Text] [Related]

  • 32. Deletion of the p27Kip1 gene restores normal development in cyclin D1-deficient mice.
    Geng Y, Yu Q, Sicinska E, Das M, Bronson RT, Sicinski P.
    Proc Natl Acad Sci U S A; 2001 Jan 02; 98(1):194-9. PubMed ID: 11134518
    [Abstract] [Full Text] [Related]

  • 33. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation.
    Rickheim DG, Nelsen CJ, Fassett JT, Timchenko NA, Hansen LK, Albrecht JH.
    Hepatology; 2002 Jul 02; 36(1):30-8. PubMed ID: 12085346
    [Abstract] [Full Text] [Related]

  • 34. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M, Martin N, Wilks DP, Tamai K, Huot TJ, Pantoja C, Okumura K, Serrano M, Hara E.
    Oncogene; 2002 Nov 21; 21(53):8067-74. PubMed ID: 12444543
    [Abstract] [Full Text] [Related]

  • 35. Early G1 growth arrest of hybridoma B cells by DMSO involves cyclin D2 inhibition and p21[CIP1] induction.
    Ponzio G, Loubat A, Rochet N, Turchi L, Rezzonico R, Farahi Far D, Dulic V, Rossi B.
    Oncogene; 1998 Sep 03; 17(9):1159-66. PubMed ID: 9764826
    [Abstract] [Full Text] [Related]

  • 36. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.
    Tsutsui T, Hesabi B, Moons DS, Pandolfi PP, Hansel KS, Koff A, Kiyokawa H.
    Mol Cell Biol; 1999 Oct 03; 19(10):7011-9. PubMed ID: 10490638
    [Abstract] [Full Text] [Related]

  • 37. A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1).
    Alevizopoulos K, Catarin B, Vlach J, Amati B.
    EMBO J; 1998 Oct 15; 17(20):5987-97. PubMed ID: 9774342
    [Abstract] [Full Text] [Related]

  • 38. Lovastatin inhibits mesangial cell proliferation via p27Kip1.
    Terada Y, Inoshita S, Nakashima O, Yamada T, Kuwahara M, Sasaki S, Marumo F.
    J Am Soc Nephrol; 1998 Dec 15; 9(12):2235-43. PubMed ID: 9848777
    [Abstract] [Full Text] [Related]

  • 39. Role of p27(Kip1) in human intestinal cell differentiation.
    Deschênes C, Vézina A, Beaulieu JF, Rivard N.
    Gastroenterology; 2001 Feb 15; 120(2):423-38. PubMed ID: 11159883
    [Abstract] [Full Text] [Related]

  • 40. Retinoic acid-mediated growth arrest of EBV-immortalized B lymphocytes is associated with multiple changes in G1 regulatory proteins: p27Kip1 up-regulation is a relevant early event.
    Zancai P, Cariati R, Rizzo S, Boiocchi M, Dolcetti R.
    Oncogene; 1998 Oct 08; 17(14):1827-36. PubMed ID: 9778049
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.